David Colleran - 14 Mar 2022 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: EVP, General Counsel, Corp Sec
Signature: /s/ David Colleran
Issuer symbol: ANIK
Transactions as of: 14 Mar 2022
Net transactions value: +$39,978
Form type: 4
Filing time: 16 Mar 2022, 09:01:06 UTC
Previous filing: 15 Mar 2022
Next filing: 12 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Purchase	$39,978	+1,500	+22%	$26.65	8,367	14 Mar 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 14, 2022, Mr. Colleran purchased 1,500 shares in multiple trades ranging from $26.58 to $26.71. The price reported above reflects the weighted average purchase price. Mr. Colleran undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected.

Content

On March 14, 2022, Mr. Colleran purchased 1,500 shares in multiple trades ranging from $26.58 to $26.71. The price reported above reflects the weighted average purchase price. Mr. Colleran undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected.